Malaria is responsible for nearly one million deaths annually, and the increasing prevalence of multi-resistant strains of Plasmodium falciparum poses a great challenge to controlling the disease. A diverse set of flavones, isosteric to 4(1H)-quinolones, were prepared and profiled for their antiplasmodial activity against the blood stage of P. falciparum W2 strain, and the liver stage of the rodent parasite Plasmodium berghei. Ligand efficient leads were identified as dual stage antimalarials, suggesting that scaffold optimization may afford potent antiplasmodial compounds.
Keywords: 1,8-diazabicycloundec-7-ene; CQ; DBU; DMF; Dual stage inhibitor; EEF; Flavone; LE; Ligand efficiency; Malaria; N,N-dimethylformamide; N-bromosuccinimide; NBS; PfNDH2; Plasmodium falciparum NADH:ubiquinone oxidoreductase; SAR; chloroquine; exo-erythrocytic form; ligand efficiency; structure–activity relationships.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.